Impact of source and manufacturing of collagen matrices on fibroblast cell growth and platelet aggregation by Böhm, Stefanie et al.
materials
Article
Impact of Source and Manufacturing of Collagen
Matrices on Fibroblast Cell Growth and
Platelet Aggregation
Stefanie Böhm 1, Christine Strauß 2, Stefan Stoiber 2, Cornelia Kasper 1,2 ID and
Verena Charwat 2,*
1 Technical Chemistry, Leibniz University Hannover, 30167 Hannover, Germany;
stefanie.boehm@clariant.com (S.B.); cornelia.kasper@boku.ac.at (C.K.)
2 Department of Biotechnology, University of Natural Resources and Life Sciences, 1190 Vienna, Austria;
christine.strauss@students.boku.ac.at (C.S.); stef.stoiber@chello.at (S.S.)
* Correspondence: verena.charwat@boku.ac.at; Tel.: +43-1-47654-79019
Received: 10 July 2017; Accepted: 5 September 2017; Published: 15 September 2017
Abstract: Collagen is a main component of the extracellular matrix. It is often used in medical
applications to support tissue regeneration, hemostasis, or wound healing. Due to different sources of
collagen, the properties and performance of available products can vary significantly. In this in vitro
study, a comparison of seven different collagen matrices derived from bovine, equine, and porcine
sources was performed. As performance indicators, the scaffold function for fibroblasts and platelet
aggregation were used. We found strong variation in platelet aggregation and fibroblast growth on
the different collagen materials. The observed variations could not be attributed to species differences
alone, but were highly dependent on differences in the manufacturing process.
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1. Introduction
The extracellular matrix (ECM) component collagen is one of the most abundant proteins in
the human body. It plays a pivotal role in providing tensile tissue strength and tissue repair due
to its unique physical and biological properties including hemostatic function, biodegradability,
enhancement of new collagen deposition, cell recruitment, control of proteolytic activity in chronic
wounds, and low-antigenic response [1,2]. Based on its characteristics, collagen is one of the most
widely used biomaterials in the field of tissue engineering, advanced wound care, and regenerative
medicine, and is extensively investigated for clinical applications [3,4]. Collagen is a natural
biopolymer, which can be isolated from different species and tissue sources as well as subjected
to a variety of scaffolding procedures. Depending on the manufacturing approach, it is processed into
fibers, meshes, porous sponges, or hydrogels [2].
The main sources for collagen are donated human tissue or large mammals such as cattle, horses,
pigs, or sheep. Other sources, e.g., fish and jelly fish, are used as well, although less frequently [5,6].
Collagen is mainly derived from tissues such as skin, tendons, pericardium, or inner organs such as
small intestine submucosa, forestomach, or bladder. As collagen is an evolutionary, highly conserved
molecule, mammalian-derived collagen is generally well tolerated in human. During the healing
process, collagen is enzymatically degraded and remodeled over time, and eventually replaced by the
body’s own collagen [7,8].
To modify the properties of collagen, it can be blended with other ingredients such as
polysaccharides e.g., alginate, oxidized regenerated cellulose (ORC), glycosaminoglycans, proteins
e.g., elastin, and drugs such as antimicrobials e.g., silver, antibiotics, or enzymes e.g., thrombin [9–11].
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This can lead to distinct changes in clinical outcome. It was shown that a combination of collagen and
elastin performed best with regard to scar contraction in a deep dermal wound model in pigs [9,12].
Medical collagen products are often used as a mechanical scaffold to support cell invasion or as a
sponge-like device that is able to store large amounts of fluids such as wound exudate or blood [13].
Moreover, its porous structure enables nutrient and oxygen supply throughout the matrix, thereby
supporting wound healing and tissue regeneration. It provides a microstructure that is highly amenable
for cell attachment, migration, and spreading [14,15]. This is not only triggered by the collagen lattice
geometry, but even more by specific binding sites to which cells can attach either directly or through
intermediary proteins [16]. It was shown that collagen is able to interact with cellular integrins and
supports different cellular functions and regeneration via chemotactic signals [17].
An additional characteristic of collagen molecules is the activation of platelets. When platelets
come in contact with collagen, a reaction cascade is started, which finally leads to an aggregation
of platelets. The aggregated platelets form a clot that effectively reduces bleeding [18]. Importantly,
the complete platelet aggregation cascade can only be induced by native collagen. Monomeric and
fibrillar collagens effectively support platelet adhesion, whereas the native, triple-helical structure
of collagen and the polymerization of the monomeric collagen is required for collagen-induced
platelet aggregation and secretion [19–21]. A fast integrin mediated adhesion was shown for native
but not for denatured collagen [22]. This illustrates the importance of maintaining the nativeness
and active binding sites of collagen and thereby the quality of the collagen product during the
manufacturing process.
In the production of collagen-based products, different methods can be used depending on the
origin of the raw material and the intended application of the final product. A general overview of the
process flow for the products used in this investigation is shown in Figure 1A. In each case, a thorough
cleaning of the raw material is needed to eliminate potential biological hazards. For animal-derived
products, the process has to ensure cell removal to avoid any inflammatory and rejection reactions
based on remaining α-gal (galactose-alpha-1,3-galactose) epitopes of the animal source [23]. During the
first step of production the materials are cleaned mechanically from other tissues and then subjected to
chemical treatment to decellularize them [24,25]. This is often performed by a treatment of alkaline
and or acid solutions for several hours or even days. In order to reduce the density of the source
tissues the materials can be milled in consecutive steps and diluted with aqueous solutions [10,26–29].
Most manufacturing processes include lyophilization in order to achieve good shelf life at room
temperature. By this sequence of process steps, an open porous structure is created that provides
a large surface for cell interaction and the absorbance of fluids. Although this general procedure is
used for the production of all materials included in this study, it is expected that even rather small
differences in the production may result in a different performance of the final products. The use of
chemicals and treatment conditions such as organic chemicals for degreasing or elevated temperature
will influence the intactness of the collagen fibrils and may influence the effectiveness of the product.
Thermal treatment of the collagen will lead to a destruction of the triple helix, resulting in an uncoiled,
gelatin-like structure (see Figure 1B) that does not achieve native interaction with cell receptors.
As each company uses their own variation of the general treatment regime, differences in the quality
and functionality of the final products can be expected.
The aim of this investigation was to show the impact of different collagen sources and influences
that may derive from variations in the production process on the performance of the products in an
in vitro approach. In order to analyze a more homogenous group of collagen matrices, we have focused
on matrices made from tissue sources rich in collagen type I such as hides and tendon. The analysis of
collagen matrices based on type II collagens found in cartilage, for example, is beyond the scope of
this manuscript. Therefore, commercial available products such as Promogran, Suprasorb C, Nobakoll,
and Kollagen resorb were compared to bovine, porcine, and equine collagen matrices manufactured
based on the proprietary 2C Technology by MedSkin Solutions Dr. Suwelack AG. The according
2C-technology serves as a platform for customized wound care solutions and hemostat products.
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To estimate the functionality of collagen matrices for medical applications, the use as hemostat and
scaffold for regenerative as well as for wound healing purposes was chosen. As fibroblasts and
platelets are both able to interact biologically with native collagen via receptors, the aggregation of
platelets and the growth of fibroblasts were selected as model systems.
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cannot be distinguished from the matrix background in light microscopy (see Figure 2). DAPI 
staining was used to stain the cell nuclei while TRITC-phalloidin was applied for cytoskeletal 
staining. Phalloidin staining (Figure 2) revealed the cytoskeletal structure in the 2D samples and 
indicated cell shape in the 3D samples. However, DAPI staining provided less background and 
allowed better evaluation of cell distribution and number in the 3D samples, especially for high cell 
densities (see also Figure S1). DAPI pictures at reduced magnification were taken from the top side 
of each matrix after different incubation times (Figure 3). On all tested materials, bright blue spots 
representing the cell nuclei were found, confirming cell attachment. Generally, a relatively 
homogeneous distribution of cells on the collagen disks was observed, indicating reliable seeding 
procedures. Over time, the blue fluorescence signal increased for all matrix materials except 
Promogran and Nobakoll. Increasing numbers of nuclei further confirmed successful cell attachment 
to the substrate as well as viability and proliferation. After two weeks of cultivation, most materials 
were completely crowded with a densely packed cell layer. However, on Promogran disks cell 
numbers appeared similar on day 7 as directly after seeding, indicating no cell proliferation. On day 14, 
only a few nuclei could be identified on the matrix, which suggested cell detachment or cell death. 
For Nobakoll, strong matrix degradation was observed starting at day 2. On day 10, only a few 
remnants of the material with low cell numbers were present in the well. On day 14, the matrix had 
been completely degraded, therefore no picture could be taken. Similarly, the Suprasorb C disks also 
showed strong degradation over the experimental time. As expected for 3D cell cultures, relatively 
high background fluorescence was observed in all samples as a result of cells growing not only in a 
single layer on the matrix surface but spreading deeper into the scaffold. Due to cell distribution in 
the Z-direction and background fluorescence, no quantification of the fluorescence pictures 
regarding fluorescence intensity or count of nuclei was performed. DAPI staining provided useful 
information; however, further experiments were performed to obtain quantitative measurements on 
cellular activity by using the MTT assay and CellTiter-Blue assay. In the assay, absorption values are 
proportional to the overall metabolic activity in the sample, which is influenced by cell number, 
viability, proliferation, and metabolic activity per cell. MTT results are plotted in Figure 4. MedSkin 
Figure 1. Collagen scaffolding. (A) Basic workflow for the manufacturing of collagen matrices
compared in this investigation; (B) Top: Intact, native collagen characterized by an intact triple helix;
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2. Results
2.1. Matrix Evaluation in 3D Cell Culture
Cell-matrix i teraction is a crucial factor for the clinical o tcome of biomat rials applied as wound
dressi gs a d generative mplants. In an in vitro setup we modeled the cell matrix contact and
monitored cell spreading and ctivity.
First, a qualitative characterization of cell attachment and distribution on the different matrices
was performed. Fluorescence staining was employed to identify cells in the 3D matrix, since they cannot
be distinguished from the matrix background in light microscopy (see Figure 2). DAPI staining was
used to stain the cell nuclei while TRITC-phalloidin was applied for cytoskeletal staining. Phalloidin
staining (Figure 2) revealed the cytoskeletal structure in the 2D samples and indicated cell shape in
the 3D samples. However, DAPI staining provided less background and allowed better evaluation of
cell distribution and number in the 3D sampl s, especially for high cell densities (see also Figure S1).
DAPI ictures at reduced magnification were taken from the op side of each matrix after different
incubati n times (Figure 3). On all tested materials, bright blue spots representing the cell nuclei
were found, confirming cell attachment. Generally, a relatively homogeneous distribution of cells
on the collagen disks was observed, indicating reliable seeding procedures. Over time, the blue
fluorescence signal increased for all matrix materials except Promogran and Nobakoll. Increasing
numbers of nuclei further confirmed successful cell attachment to the substrate as well as viability and
proliferation. After two weeks of cultivation, most materials were completely crowded with a densely
packed cell layer. However, on Promogran disks cell numbers appeared similar on day 7 as directly
after seedi g, indicating no cell proliferation. On day 14, o ly a f nuclei could be identified on the
matrix, which suggested c ll detachment or cell death. For Nobakoll, strong m trix degradation was
observed starting at day 2. O day 10, only a few remnants of the material with low cell numbers were
present in the well. On day 14, the matrix had been completely degraded, therefore no picture could
be taken. Similarly, the Suprasorb C disks also showed strong degradation over the experimental
time. As expected for 3D cell cultures, relatively high background fluorescence was observed in all
samples as a result of cells growing not only in a single layer on the matrix surface but spreading
deeper into the scaffold. Due to cell distribution in the Z-direction and background fluorescence,
no quantification of the fluorescence pictures regarding fluorescence intensity or count of nuclei was
performed. DAPI staini g provided useful information; however, fu ther experiments were performed
to obtain quantitative measurements on cellular activity by using the MTT assay and CellTiter-Blue
assay. In the assay, absorption values are proportional to the overall metabolic activity in the sample,
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which is influenced by cell number, viability, proliferation, and metabolic activity per cell. MTT results
are plotted in Figure 4. MedSkin Solutions Dr. Suwelack AG (MDS) bovine collagen was always added
as a control to allow comparison between the assays. For most matrix materials MTT signals rose over
the incubation time, indicating increasing numbers of viable cells. The strongest cell proliferation was
observed on MDS bovine and equine collagen. Slightly lower cell growth was found on Kollagen
resorb (significant from day 7 on), followed by MDS porcine collagen (significantly lower than MDS
bovine collagen on days 1, 10, and 14). The weak signal increase in Suprasorb C samples can be
attributed to the considerable degradation of this material over the cultivation time. MTT signals of
Promogran stayed very low over the entire cultivation period, confirming that cells did not proliferate
on this material. During cell cultivation, it was noted that the medium color in wells containing
Promogran rapidly changed from red to yellow, indicating a pH-shift towards acidic conditions. A low
pH of 6.5 was confirmed by pH measurements, which is clearly below the ideal range of 7.2–7.4 for
complete cell culture media. For Nobakoll, MTT results could only be obtained at day 0 and day
1 due to strong matrix disintegration. Overall, the metabolic activity results confirmed the initial
observations based on nuclear staining.
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Figure 2. Microscopic images of NIH 3T3 fibroblasts in standard 2D culture on polystyrene surface
and in 3D culture on MDS bovine collagen matrix (48 h incubation; 35,000 cells/cm2 seeding density).
Cells were stained with DAPI (blue, nuclei) and TRITC-conjugated phalloidin (red, f-actin). Scale bar
represents 250 µm.
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In an attempt to obtain metabolic information from the Nobakoll samples, an additional test 
was performed. The CellTiter-Blue assay works similarly to the MTT assay based on the intracellular 
conversion of a dye. However, the CellTiter-Blue protocol is simpler and requires only a single 
pipetting step. It was possible to acquire measurement results for all timepoints, despite the loss of 
solid matrix (see Figure 5). The constantly low read out for Suprasorb C and Nobakoll can be 
attributed to matrix degradation and the resulting loss in the cell adhesion area. For the other matrix 
materials, results comparable to the MTT assay were found. Only for MDS equine collagen were 
surprisingly high values recorded from day 7 to 14. Statistical analysis revealed significant 
differences (p < 0.001) between all pairs of materials except Suprasorb C vs. Nobakoll on days 10 and 
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assay was not applied to Promogran samples, since the assay read out could be altered by the 
reduced pH values. By contrast, in the MTT assay a solution containing HCl is added to dissolve the 
crystals, resulting in acidic pH regardless of the original sample pH.  
Figure 4. M T absorbance values (absorption at reference wavelength and blanks sub racted) for
up to t o weeks of cell c lture on diff rent collagen matrix materials. (A,B) Bar charts for bovine
co lagen scaff l i t rs, respectively. Data of equine and porcine materials is
hown in (C,D), respectively. Both (C,D) contain additional measurements of MDS bovine collagen for
comparison between the different tests.
In an attempt to obtain metabolic information from the Nobakoll samples, an additional test
was performed. The CellTiter-Blue assay works similarly to the MTT assay based on the intracellular
conversion of a dye. However, the CellTiter-Blue protocol is simpler and requires only a single
pipetting step. It was possible to acquire measurement results for all timepoints, despite the loss
of solid matrix (see Figure 5). The constantly low read out for Suprasorb C and Nobakoll can be
attributed to matrix degradation and the resulting loss in the cell adhesion area. For the other matrix
materials, results comparable to the MTT assay were found. Only for MDS equine collagen were
surprisingly high values recorded from day 7 to 14. Statistical analysis revealed significant differences
(p < 0.001) between all pairs of materials except Suprasorb C vs. Nobakoll on days 10 and 14 and
between all except Suprasorb C vs. Nobakoll and MDS porcine collagen vs. MDS bovine collagen on
day 7. On day 4, MDS equine collagen results were significantly higher than all others (p < 0.05), while
Suprasorb C and Nobakoll values were significantly lower than all others except Nobakoll vs. MDS
porcine collagen. On day 1, only Suprasorb C vs. MDS equine collagen showed a significant difference
(p = 0.088). On day 0, no significant differences were found. CellTiter-Blue assay was not applied to
Promogran samples, since the assay read out could be altered by the reduced pH values. By contrast,
in the MTT assay a solution containing HCl is added to dissolve the crystals, resulting in acidic pH
regardless of the original sample pH.
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3. Discussion
The use of collagen for medical products has been established for more than four decades.
Collagen scaffolds are used in hemostasis, wound healing, and regenerative medicine, e.g., as a dermal
template or carrier for implantable scaffolds.
In order to provide an optimal environment for cellular ingrowth as well as platelet aggregation,
the nativeness of the collagen as well as its helical structures and cellular binding sides need to be
retained. Brown et al. conducted animal studies to characterize the influence of different ECM-based
implants on the regeneration of surgical wounds. Materials that provided a near native composition
showed the most promising results [31].
The nativeness of the products strongly depends on the manufacturing process. A thorough
but mild decellularization, strict control of temperature, and an avoidance of residual chemicals,
for example, is needed to obtain effective products in order to minimize or avoid encapsulation
and inflammatory reactions [25]. All collagen sheets used in this study were manufactured by
lyophilization; however, exact process parameters are unknown for the commercial products. Since
different ways of extraction, processing, and sterilization may influence the biologic response with
regard to cell attachment and migration as well as hemostasis, the collagen matrices were compared
with reference materials of bovine, equine, and porcine origin fabricated at MedSkin Solutions
Dr. Suwelack AG that were processed using essentially similar protocols. It is noteworthy in this
regard that it was previously shown that the microstructure of collagen-based matrices such as density
or fiber orientation influences cellular morphology and behavior [32,33]. Raster Electron Microscopic
Analyses of the collagen matrices used in this study revealed structural differences of the materials
that might further influence their performance with regard to fibroblast adhesion and growth (data not
shown). Structural differences are not only a function of collagen composition, but also of processing
parameters such as concentration or freezing rate [34,35].
In addition to the impact of the manufacturing process, this gives the opportunity to compare
the influence of the collagen source on the matrix performance. The collagen sources used in this
investigation were bovine and porcine hides as well as equine Achilles tendons. In this regard, Angele
et al. compared the use of bovine and equine tendon collagen, which were basically prepared in the
same way for use in cell culture. They found a higher thermal stability of equine collagen compared
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to bovine collagen and a tendency of equine collagen to rupture under higher mechanical resistance
compared to bovine collagen matrices [36].
All materials investigated in this study are intended to be used as wound dressings or hemostats;
therefore, fibroblasts and platelets were chosen as clinically relevant cell types to analyze the influence
of the manufacturing process as well as the collagen source on the performance of the materials [37,38].
One of the main functions of collagen in wounds is the guidance of cell growth and migration
during the proliferation and remodeling phase of the healing process [5,39]. These favorable properties
for cell attachment and growth make collagen a promising material for clinical application. Our study
confirmed that successful cell attachment was possible on the different collagen-based matrix materials.
DAPI staining showed that cell attachment was clearly visible on all bovine matrices already on day 0.
However, initial pictures of porcine and equine materials showed only a very sparse presence of
cells. This observation suggests that cell attachment occurred at different speeds on the different
materials. Cells might have not yet been completely attached to some of the materials and were
washed away during the staining procedure. Another possibility is that cells were absorbed deeper
into the porcine and equine scaffolds due to different wettability and pore size. However, DAPI
pictures and metabolic activity analysis at days 7 and 14 showed cell survival and proliferation. This
finding confirmed successful cell seeding, even on materials that initially showed a low presence of
cells. Qualitative findings obtained from DAPI staining were confirmed by using the quantitative
MTT and CellTiter-Blue® metabolic assays. Overall MDS bovine and equine collagen showed highest
cell proliferation, followed by Kollagen resorb and MDS porcine collagen. Low metabolic activity
was detected for Suprasorb C and Nobakoll due to material degradation and for Promogran due to
pH reduction that interfered with cell growth. This effect can be attributed to the ORC fraction of
the product Promogran. A drop in pH level was described for oxidized cellulose hemostatic agents,
although some authors describe differences between investigated media types [40,41]. The shift to
a more acidic value might on the one hand occur by degradation, as the depolymerization leads to
the release of acidic groups [42]. On the other hand, the fibroblasts themselves might lower the pH.
Wagenhäuser et al. hypothesized that the fibrous components of the ORC material might alter cell
function, leading fibroblasts to release acid or to undergo apoptosis.
Another important parameter for biomaterials in clinical application is the balance between
stability and degradability. Stability is needed to provide a scaffold for cell growth and migration
as well as protection from matrix metalloproteinases (MMPs). In chronic wounds, elevated levels
of MMPs cause excessive collagen degradation. Here, collagen-based wound dressings can help to
re-establish an equilibrium since they act as an additional substrate for MMPs and thereby protect
the patient’s collagen from breakdown. In this regard, a recent study by Tati et al. [43] (submitted)
showed a higher capacity of wound dressings that contain native collagen to bind and inactivate
MMPs. Nevertheless, all tested materials are bioresorbable and designed to eventually degrade and be
replaced by freshly grown patient tissue. Degradation products enhance the migration of fibroblasts,
epithelial, and vascular endothelial cells into the wounded region to form the granulation tissue [44].
In our study, we found strong differences in the degree of degradation of the different materials. For
most collagen matrices, no obvious loss in material amount, size, or structure was observed during
our two-week experimentation time, indicating relatively slow degradation. However, Nobakoll and
Suprasorb C started to degrade within a few days of cultivation time and very little to no material was
left by the end of the experiment. Together with the matrix, the adhering cells were gradually lost,
resulting in low metabolic activity signals in the MTT assay.
Our in vitro findings are intended to give a first estimation of the behavior in a wound, but it
has to be considered that in vivo a more complex set of different cell types, bodily fluids, possible
microbial contamination, and mechanic agitation influences the matrix degradation process.
In addition to the analysis of cell growth on the different collagen matrices, the aggregation of
platelets on the matrix surface was investigated. Collagen is regarded as being beneficial in blood
coagulation, as the collagen fibrils enable platelets to adhere on the surface and in this way enhance the
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natural aggregation and degranulation, initiating the formation of a physiological platelet plug [11,45].
Therefore, collagen matrices are widely used as hemostatic dressings. Note that the aggregation
cascade can only be induced by native collagen as it provides the intact binding sites needed for
interaction with the platelets [22]. All materials used in this study except Nobakoll and Suprasorb C
claim to support the hemostasis process in wounds. Although it can be assumed that all materials will
contribute to hemostasis by absorbing diffusing blood and reducing bleeding based on their capillary
activity, the ability to induce the aggregation of platelets varies to a large extent. In the present study,
no aggregation was observed for Kollagen resorb, Nobakoll, or Promogran. Bovine, porcine, and
equine collagen of MDS induced aggregation effectively, whereas aggregation using Subrasorb C was
somewhat delayed. These findings suggest that the native structure in bovine, porcine, and equine
collagen of MDS is mostly intact and available at the surface, resulting in a good platelet-collagen
interaction. For Kollagen resorb, Nobakoll, and Promogran, this interaction was not observed, which
might be due to a destruction of the native structure or a blocking of the surface due to product
composition. Promogran is composed of a mixture of ORC and collagen (45%:55%), so the surface
of the collagen might be compromised by ORC fibers. Suprasorb C reveals some potential to induce
aggregation, but the delay suggests that less native collagen structures are accessible for platelet
interaction. In this context, Wagner et al. used an in vitro approach by testing platelet activation in
PRP and clotting time in whole blood samples using collagen, gelatin, and ORC matrices. They ranked
the overall hemostatic activity as a combination of the relative performance of each test conducted,
suggesting that collagen was the most effective, followed by gelatin and ORC [46]. Interestingly, in the
current study different collagen products were used and they showed varying activity which might
be based on different production processes. A similar suggestion was made by Eloy et al. Hemostats
were tested in vitro for their ability to contribute to the plasmatic and cellular activation steps of the
coagulation cascade. The potential of collagen to act as a powerful hemostatic agent was confirmed,
but significant changes between different commercial collagen preparations were also observed. These
differences may be due to different extraction and purification procedures, or different modes of
sterilization of the products, resulting in changes in the bioactive conformational structure of the
collagen and thus a limited extent of aggregation [47].
As most of the products used in this study are designed as wound dressings, the activation of
platelets are not the foremost indication of these products. However, it should be kept in mind that
natural hemostasis is the first step in wound healing [48]. The degranulation of platelets enables the
release of platelet-derived growth factor (PDGF) that is beneficial in wound healing. Treatment of
injuries or inflamed body parts with activated PRP showed good clinical results, indicating that the
activation of platelets by collagen might be beneficial in the wound healing cascade, resulting in a
structured regeneration of damaged tissue [4,49,50].
Taken together, our analysis shows that collagen matrices that originated from the same source
but were processed differently (e.g., bovine hides) explore a more pronounced difference with regard
to performance in cell growth and platelet aggregation compared to collagen matrices from different
animal sources that were processed under similar conditions. We therefore conclude that although
there is an influence of the collagen source on its properties, the processing of the collagen seems
to have a stronger impact. A manufacturing process that maintains an open porous structure and
nativeness of the collagen, and thereby maintains its binding sites for cell attachment, ensures optimal
cell migration and proliferation.
4. Materials and Methods
4.1. Cell Culture
NIH 3T3 cells (ACC 59, DMSZ, Braunschweig, Germany) were cultivated in Dulbecco’s
modified Eagle’s medium (DMEM; D5648; Sigma Aldrich, Munich, BY, Germany) supplemented
with 10% fetal calf serum (FCS; A15-101; PAA Cell Culture Company, Pasching, Austria) and 1%
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penicillin/streptomycin (P4333; Sigma Aldrich), in a humidified environment at 37 ◦C and 5% CO2
(standard incubator Hera Cell 240, Heraeus Holding GmbH, Hanau, Germany). Cell culture reagents
and chemicals were obtained from Sigma Aldrich unless indicated differently. Culture flasks and well
plates were purchased from Sarstedt AG (Nümbrecht, Germany).
4.2. Collagen Matrices
In this comparative study, seven different collagen matrix materials were investigated: Promogran,
Suprasorb C, Nobakoll, and Kollagen resorb as well as sterile bovine, porcine, and equine collagen
matrices provided by MedSkin Solutions Dr. Suwelack AG (MDS), Billerbeck, Germany (later referred
to as MDS bovine collagen, MDS porcine collagen, and MDS equine collagen). The MDS collagen
matrices were manufactured by the same method, but using different animal origins. In brief,
bovine and porcine collagen was made of hides. The collagen-rich dermal layer was used for
further processing. The dermal layer was treated under alkaline conditions to remove residues
and then adjusted to an acidic pH value. The skin was then milled and diluted to obtain the final
collagen concentration prior to freeze-drying of the material. Matrices with a final thickness of
2 mm were sterilized using gamma radiation. Equine collagen was produced in a similar way.
Equine tendons were thoroughly defleshed before starting the alkaline treatment. The MDS collagen
preparations are intended to be used for tissue regeneration, as wound dressing materials as well as
for hemostatic purposes.
Promogran (REF: M772123) is made of 55% bovine collagen and 45% ORC and was purchased from
Systagenix Wound Management GmbH, Hamburg, Germany (parent company: Acelity, San Antonio,
TX, USA). Promogran is prepared as a sterile, 3-mm thick porous sheet by lyophilization of a collagen
and ORC fiber suspension. Its main clinical use is topical application in chronic non-healing wounds,
where it forms a gel and absorbs exudate during a slow degradation phase. Additionally, Promogran
can be used on bleeding surface wounds.
Suprasorb C (REF: 20,483, Lohmann & Rauscher GmbH & Co. KG, Neuwied, Germany) is
an 8-mm thick collagen matrix prepared from bovine hides (Corium) by freeze-drying. Its main
application is treatment of skin areas with large superficial tissue defects, especially chronic stagnant
wounds. The porous structure of Suprasorb C provides a capillary structure for liquid absorption to
remove wound exudate. The collagen matrix is intended to support skin cell ingrowth. The product is
manufactured aseptically.
Kollagen resorb (REF: RK1209, Resorba Medical GmbH, Nürnberg, Germany) is a sterile 3–4-mm
thick, soft, dimensionally stable collagen sponge for local hemostasis. It is made of collagen fibrils of
equine origin (horse Achilles tendon) and used as a hemostatic agent in cases of venous, capillary, and
diffuse bleeding as well as a temporary skin cover.
Nobakoll (REF: 781,110, NOBA Verbandmittel Danz GmbH, Wetter, Germany, manufactured by
MBP GmbH, Neustadt-Glewe, Germany) is a 5-mm thick, sterile collagen sponge made of porcine hide
(corium) that is employed for chronic wounds and wound healing by secondary intervention.
4.3. Matrix Preparation and Cell Seeding
All matrix materials were provided as sheets with thicknesses of a few millimeters. Tests were
performed in 24- and 96-well microtiter plates. For in vitro testing, circular disks with diameters of
6 mm were prepared using a hollow punch of the appropriate size. For Promogran, a larger format
(15-mm disks) with a lower volume per cell was selected due to undetectably low MTT signals. As a
reference, MDS bovine collagen was analyzed in both formats. The matrix pieces were transferred
to a 24-well plate (15-mm disks) or 96-well plate (6-mm disks). Before cell seeding, the materials
were sterilized for 3 h by UV light treatment inside the laminar flow workbench. No alterations of
the materials were observed after UV treatment (neither macroscopically, nor by light microscopy,
nor electron microscopy; data not shown). All subsequent cell cultivation experiments were carried
out under sterile standard conditions. The matrices were moistened with cell culture medium (100 µL
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for 15-mm disks and 20 µL for 6-mm disks) and incubated for a few minutes. Then, cell suspension
was pipetted on top of each matrix to inoculate with 100 cells/mm2 (100 µL containing 18,000 cells
for 15-mm disks and 60 µL containing 3000 cells for 6-mm disks, unless indicated differently) and
incubated for 1.5 h to allow cell adhesion. Next, 200 or 500 µL cell culture medium were added to the
6- and 15-mm disks, respectively. A medium exchange was performed on days 7, 10, and 12.
4.4. Nuclear Staining
To visualize the cell distribution and number, 4′,6 diamidino-2-phenylindole dihydrochloride
(DAPI; D8417; Sigma Aldrich) staining was performed. The blue fluorescent nuclear dye preferentially
binds to dsDNA and less effectively to RNA, resulting in bright nuclear staining of mammalian cells.
The matrices were washed with phosphate buffered saline (PBS; P38135; Sigma Aldrich) and then the
cells were fixated on the matrices with ice-cold ethanol (96%) for 1 h at 4 ◦C in the dark. After rinsing
the matrices with PBS, the DAPI solution was added (1:500 DAPI–stock solution (1 mg/mL) in PBS)
and incubated for 30 min, at 37 ◦C in the dark. Subsequently, cells were visualized using a fluorescence
microscope (Olympus IX 50 Olympus Corporation, Tokyo, Japan) equipped with a DAPI filter block.
4.5. F-Actin Staining
For the staining of cytoskeletal f-actin fibers, TRITC-conjugated phalloidin (R415; Molecular
Probes; reconstituted to 200 units/mL in methanol) was used. The cells were fixated with 4%
paraformaldehyde (F8775; Sigma Aldrich) in PBS for 20 min at ambient temperature on an orbital
shaker. Then, 0.1% Triton-X 100 in PBS was applied for 2 min for membrane permeabilization.
The samples were rinsed with PBS, and submerged in a staining solution containing 1% FCS,
4 units/mL phalloidin, and 2 µg/mL DAPI in PBS. After 30 min incubation at ambient
temperature on an orbital shaker, the samples were rinsed twice with PBS and analyzed using a
fluorescence microscope.
4.6. Metabolic Activity Assay
Viability of the cells was analyzed by (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium-bromid)
(MTT) assay (M5655, Sigma Aldrich) on days 0 (directly after seeding), 1, 4, 7, 10, and 14. The MTT
assay is a widely used spectrophotometric method for viability evaluation through the metabolic
activity of mitochondria in living cells. For the analysis, the matrices were transferred to a fresh plate.
Materials of 15-mm diameters were incubated with 660 µL MTT solution (600 µL DMEM + 60 µL MTT
stock solution (5 mg/mL PBS, sterile)) for 4 h at 37 ◦C and 5% CO2. Thereafter, 600 µL solubilization
solution containing 10% SDS (w/v) in 0.01 M HCl was added and incubated overnight at 37 ◦C.
The next day, the dissolved solution was transferred to a 96-well plate (100 µL/well) for testing.
The absorption was measured at 570 nm (and 630 nm as a reference value) in a microplate reader
(Model 680, Multiskan Thermo Fisher Scientific Inc., Waltham, MA, USA). Cell culture medium
on matrix materials without cells was used to generate blank values. For the experiments with
6-mm diameter disks, the applied volumes were 110 µL MTT solution and 100 µL solubilization
solution. Replicate numbers were four for the 15-mm disks and six for the 6-mm disks. Additionally,
a CellTiter-Blue assay (G8080; Promega, Mannheim, Germany) was performed. In this fluorometric
viability assay, the metabolic activity of the cells is measured by the conversion of the indicator dye
resazurin. The matrices were transferred to a fresh plate and 100 µL cell culture medium and 20 µL
CellTiter-Blue were added to each well. After 2.5 h, 100 µL per well were transferred to a fresh well
and emission was measured at 590 nm with 544 nm excitation (Fluoroskan Ascent Thermo Fisher
Scientific Inc., Waltham, MA, USA). All data was normalized to MDS bovine collagen at day 14.
Two-way ANOVA (with Tukey multiple comparisons test) was performed for statistical analysis.
Materials 2017, 10, 1086 12 of 14
4.7. Platelet Aggregation
The materials were tested in an platelet aggregation assay according to Born [30]. This test is
based on an optical change of turbidity PRP. When platelets are activated in PRP and start to aggregate,
a clearance of the solution can be observed. Speed and magnitude of the reduction of optical density
are parameters for effective aggregation. The photometer used for aggregation was operated with
an light-emitting diode (LED) light source (660 nm) to detect the absorption of the PRP. The cuvette
was heated to 37 ◦C by using a flow through a water bath system. The change of absorbance was
tracked by a voltmeter with an A/D converter (Voltcraft digital multimeter VC 840, Conrad Elektronik,
Hirschau, Germany) and the data was transferred to a personal computer using the software RealView
1.0 (Abacom, Ganderkesee, Germany).
For testing the aggregation, porcine blood was used. It was treated with sodium citrate (3.2%) to
avoid clotting. The blood was centrifuged for 10 min at 200 × g (Centrifuge: Heraeus Biofuge Stratos,
Thermo Fisher Scientific, Vienna, Austria) and the platelet-rich supernatant was collected (PRP). Then,
1.4 mL of PRP was transferred in a cuvette and a circular sample with a diameter of 8 mm was added.
The cuvette was placed inside the photometer, which was adjusted to 37 ◦C. Under vigorous stirring,
which is required to activate the aggregation, the change of optical density (wavelength: 660 nm) of the
solution was tracked and recorded for at least 5 min and up to 10 min. The change in optical density
was expressed in mV (output of the device). Tests were performed in triplicate for the bovine materials
and in duplicate for all other samples. The general principle of the Born test is depicted in Figure 6A.
To quantify the aggregation, the inflection point of the clotting graph was calculated. To reduce
background noise a moving average over 10 s was calculated, and based on these data the inflection
point was calculated. The time until the inflection point was considered as a measure to estimate the
speed of aggregation.
5. Conclusions
The analysis of collagen harvested from bovine, porcine, and equine sources revealed that, in
principle, all three species are suitable for cellular growth and platelet aggregation. Overall, bovine and
equine collagen performed better than the porcine collagen matrix. However, the structural features
such as the native collagen triple helical structure as well as the cellular binding sites influenced by
the manufacturing process show a higher impact. The biologic response of cells and platelets to the
different products varied widely in this regard. Although not all different production processes are
known in detail, it can be concluded that the more efficiently the structural integrity and biological
activity of the collagen can be maintained during manufacturing, the more physiological cellular
interaction will be observed.
Supplementary Materials: The following are available online at www.mdpi.com/1996-1944/10/9/1086/s1,
Figure S1: Microscopic images of NIH 3T3 fibroblasts in 3D culture on MDS bovine collagen matrix.
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